Therapeutic Effect of Proliferative Therapy (Prolotherapy) on Pain Using Injectable Hypertonic Dextrose 25% Versus Injectable Dextrose 10% in Retrodiscal Tissues in Patients With Anterior Disc Displacement With Reduction: A Randomized Clinical Trial .

Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorCairo University

About this trial

prolotherapy is an injection-based treatment method used to alleviate pain, particularly musculoskeletal pain associated with chronic ligament and tendon injuries. The process involves the injection of a solution, typically containing dextrose (a sugar), saline, or other irritants, into the affected tissues. Prolotherapy is believed to stimulate healing by causing a mild inflammatory response that promotes the regeneration of ligaments, tendons, and other connective tissues. This review explores the existing literature on the therapeutic effects of prolotherapy for pain management.

Eligibility criteria

Qualifiers

None

Disqualifiers

The clinical or radiographic signs of disc displacement without reduction .

A history of allergic reactions to any components of the injectable solution.

Blood dyscrasias and systemtic diseases .

Previous surgery of the affected joint.

Trial design

Treatments tested in this trial

  • injection of dextrose 10% in retrodiscal tissues
  • injection of dextrose 25% in retrodiscal tissues

Treatment groups

24 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators